Please login to the form below

Not currently logged in
Email:
Password:

Esteve appoints Albert Esteve as chairman of the board of directors

He succeeds Joan Esteve, who continues as chairman of the general shareholders meeting

Spanish pharmaceutical group Esteve has appointed Albert Esteve as its chairman of the board of directors to replace Joan Esteve, who will continue serving the group as chairman of the general shareholders meeting.

Albert Esteve joined the group as an assistant to general management and was appointed member of the group’s executive committee and has been chief executive officer since 2011.

Additionally, Staffan Schuberg will join as chief executive officer, effective January 2018, following more than 20 years’ experience from pharmaceutical companies such as Lundbeck, where he held the position of executive vice president and chief commercial officer.

Esteve said: “This is a new challenge that I am facing with tremendous enthusiasm.

“Regarding the CEO appointment, we feel fortunate and are much honoured to welcome Staffan Schuberg as the new executive leader of the group.”

3rd November 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics